Effectiveness and Safety of Empagliflozin in Routine Care: Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study

被引：0
|
作者：
Htoo, Phyo T.
Tesfaye, Helen
Paik, Julie M.
Wexler, Deborah J.
Najafzadeh, Mehdi
Glynn, Robert
Deruaz-Luyet, Anouk
Farsani, Soulmaz F. Fazeli
Koeneman, Lisette
Schneeweiss, Sebastian
Patorno, Elisabetta
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-1079-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1079-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effectiveness and safety of empagliflozin in routine care: Results from the empagliflozin comparative effectiveness and safety (emprise) study
    Htoo, Phyo
    Tesfaye, Helen
    Paik, Julie
    Wexler, Deborah
    Najafzadeh, Mehdi
    Glynn, Robert
    Deruaz-Luyet, Anouk
    Farsani, Soulmaz
    Koeneman, Lisette
    Schneeweiss, Sebastian
    Patorno, Elisabetta
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 40 - 41
  • [2] Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
    Patorno, Elisabetta
    Pawar, Ajinkya
    Wexler, Deborah J.
    Glynn, Robert J.
    Bessette, Lily G.
    Paik, Julie M.
    Najafzadeh, Mehdi
    Brodovicz, Kimberly G.
    Deruaz-Luyet, Anouk
    Schneeweiss, Sebastian
    DIABETES OBESITY & METABOLISM, 2022, 24 (03): : 442 - 454
  • [3] Effectiveness and safety of empagliflozin in routine care patients: interim results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
    Patorno, E.
    Pawar, A.
    Bessette, L.
    Franklin, J.
    Najafzadeh, M.
    Wexler, D.
    Deruaz-Luyet, A.
    Brodovicz, K.
    Schneeweiss, S.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S145 - S146
  • [4] Effectiveness and Safety of Empagliflozin in Routine Care Patients: Interim Results from the EMPagliflozin compaRative effectiveness and SafEty (EMPRISE) Study
    Patorno, Elisabetta
    Pawar, Ajinkya
    Bessette, Lily G.
    Franklin, Jessica
    Najafzadeh, Mehdi
    Wexler, Deborah J.
    Deruaz-Luyet, Anouk
    Brodovicz, Kimberly
    Schneeweiss, Sebastian
    DIABETES, 2020, 69
  • [5] Effectiveness and safety of empagliflozin in routine care in Europe and East Asia: results from the empagliflozin comparative effectiveness and safety (EMPRISE) study
    Karasik, A.
    Lanzinger, S.
    Tan, E. Chia-Hui
    Yabe, D.
    JungKim, D.
    Sheu, W. H-H
    Melzer-Cohen, C.
    Holl, R. W.
    Ha, K.
    Nystrom, T.
    Niskanen, L.
    Jensen, M. Linnemann
    Kyaw, M. H.
    Nunez, J.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 229 - 230
  • [6] Effectiveness and Safety of Empagliflozin in Routine Care in Europe and East Asia: Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
    Karasik, Avraham
    Lanzinger, Stefanie
    Tan, Elise C. H.
    Yabe, Daisuke
    Kim, Dae Jung
    Sheu, Wayne H-H
    Cohen, Cheli Melzer
    Holl, Reinhard W.
    Ha, Kyoung Hwa
    Nystrom, Thomas
    Niskanen, Leo K.
    Jensen, Majken Linnemann
    Kyaw, Moe H.
    Nunez, Julio
    DIABETES, 2021, 70
  • [7] Comparative Safety of Empagliflozin in Routine Care Patients: Interim Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
    Patorno, Elisabetta
    Tesfaye, Helen
    Wexler, Deborah J.
    Glynn, Robert
    Najafzadeh, Mehdi
    Bessette, Lily G.
    Zakoul, Heidi
    Koeneman, Lisette
    Deruaz-Luyet, Anouk
    Schneeweiss, Sebastian
    DIABETES, 2021, 70
  • [8] Empagliflozin selected cardiovascular and safety outcomes in routine care: first results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
    Patorno, E.
    Pawar, A.
    Franklin, J. M.
    Najafzadeh, M.
    Deruaz-Luyet, A.
    Brodovicz, K. G.
    Sambevski, S.
    Bessette, L.
    Kulldorff, M.
    Schneeweiss, S.
    DIABETOLOGIA, 2019, 62 : S329 - S330
  • [9] Empagliflozin selected cardiovascular and safety outcomes in routine care: First results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
    Patorno, E.
    Pawar, A.
    Franklin, J. M.
    Najafzadeh, M.
    Deruaz-Luyet, A.
    Brodovicz, K. G.
    Sambevski, S.
    Bessette, L. G.
    Kulldorff, M.
    Schneeweiss, S.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 104
  • [10] Empagliflozin Selected Cardiovascular and Safety Outcomes in Routine Care: First Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
    Patorno, Elisabetta
    Pawar, Ajinkya
    Franklin, Jessica
    Najafzadeh, Mehdi
    Deruaz-Luyet, Anouk
    Brodovicz, Kimberly
    Sambevski, Steven
    Bessette, Lily G.
    Kulldorff, Martin
    Schneeweiss, Sebastian
    DIABETES, 2019, 68
12345